Anna Tyrtyshnaia, Sophia Konovalova, Anatoly Bondar, Ekaterina Ermolenko, Ruslan Sultanov, Igor Manzhulo
The search for methods of cognitive impairment treatment and prevention in neurological and neurodegenerative diseases is an urgent task of modern neurobiology. It is now known that various diseases, accompanied by dementia, exhibit a pronounced neuroinflammation. Considering the significant docosahexaenoic and eicosapentaenoic polyunsaturated fatty acids' therapeutic potential, we decided to investigate and compare anti-inflammatory activity of their -acylethanolamine derivatives. As a result, we found that both -docosahexaenoylethanolamine (synaptamide) and -eicosapentaenoylethanolamine (EPEA) prevents an LPS-mediated increase in the proinflammatory cytokines TNF-α and IL-6 production in the SIM-A9 microglia culture. In an in vivo experiment, synaptamide reversed an increase in LPS-mediated hippocampal TNF-α and IL-1β, but EPEA did not. However, both compounds contributed to the microglia polarization towards the M2-phenotype. Synaptamide, rather than EPEA, inhibited the Iba-1-positive microglia staining area increase. However, both synaptamide and EPEA prevented the LPS-mediated astrogliosis. A study of BDNF immunoreactivity showed that synaptamide, but not EPEA, reversed an LPS-mediated decrease in BDNF production. Despite the more pronounced anti-inflammatory activity of synaptamide, both compounds were effective in maintaining a normal level of hippocampal long-term potentiation in neuroinflammation. The results indicate a high therapeutic potential for both compounds. However, some tests have shown higher activity of synaptamide compared to EPEA.
J Clin Psychiatry. 2011 Dec;72(12):1677-1684
[PMID:
21672499]
Dement Geriatr Cogn Disord. 2019;47(4-6):219-232
[PMID:
31311017]
Brain Behav Immun. 2011 Feb;25(2):181-213
[PMID:
20970492]
Neurobiol Aging. 2005 May;26(5):717-28
[PMID:
15708447]
J Neuroinflammation. 2004 Jul 7;1(1):12
[PMID:
15285803]
Eur J Pain. 2020 Nov;24(10):1990-1998
[PMID:
32852071]
J Neurochem. 2013 Jun;125(6):869-84
[PMID:
23570577]
Brain Res. 2019 May 15;1711:83-90
[PMID:
30639123]
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Nov;1863(11):1433-1440
[PMID:
30591150]
Biochim Biophys Acta. 2010 Oct;1801(10):1107-14
[PMID:
20601112]
Commun Biol. 2020 Mar 6;3(1):109
[PMID:
32144388]
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt A):15-18
[PMID:
28189704]
Lipids. 2011 May;46(5):463-7
[PMID:
21461869]
Brain Res Bull. 2021 May;170:74-80
[PMID:
33581310]
Lancet Neurol. 2009 Apr;8(4):382-97
[PMID:
19296921]
Cell Tissue Res. 2020 Oct;382(1):15-45
[PMID:
32944867]
Hippocampus. 2012 May;22(5):981-94
[PMID:
21125585]
J Neuroinflammation. 2019 Nov 15;16(1):225
[PMID:
31730008]
J Neuroimmunol. 2006 Jun;175(1-2):97-106
[PMID:
16626814]
Mol Aspects Med. 2018 Dec;64:34-44
[PMID:
29572109]
Nutrients. 2019 Mar 17;11(3):
[PMID:
30884890]
Br J Nutr. 2011 Jun 28;105(12):1798-807
[PMID:
21294934]
Cell Death Discov. 2019 Apr 3;5:85
[PMID:
30962951]
J Neuroinflammation. 2017 Aug 24;14(1):170
[PMID:
28838312]
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6402-6
[PMID:
11353819]
Behav Brain Res. 2019 Feb 1;359:550-559
[PMID:
30296532]
J Neurochem. 2007 May;101(3):771-81
[PMID:
17250684]
Immunity. 2017 Jun 20;46(6):957-967
[PMID:
28636962]
J Neuroinflammation. 2014 Jun 03;11:98
[PMID:
24889886]
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6034-E6043
[PMID:
28687674]
Neurotherapeutics. 2013 Oct;10(4):782-8
[PMID:
23963788]
Exp Gerontol. 2017 Oct 1;96:46-62
[PMID:
28606482]
Mar Drugs. 2020 Oct 15;18(10):
[PMID:
33076443]
Sci Rep. 2016 Mar 04;6:22276
[PMID:
26940787]
Aging Dis. 2019 Jun 01;10(3):664-675
[PMID:
31165009]
Neuroscience. 2012 Aug 2;216:133-42
[PMID:
22554776]
Int J Mol Sci. 2019 May 09;20(9):
[PMID:
31075861]
J Neurosci. 2020 Sep 2;40(36):6825-6841
[PMID:
32747440]
J Biol Chem. 2017 Jul 28;292(30):12390-12397
[PMID:
28615451]
Front Synaptic Neurosci. 2014 Mar 20;6:5
[PMID:
24688467]
Brain Behav Immun. 2019 Oct;81:484-494
[PMID:
31279682]
Front Cell Neurosci. 2015 Aug 03;9:278
[PMID:
26283915]
Mol Neurobiol. 2019 May;56(5):3295-3312
[PMID:
30117106]
J Neuroinflammation. 2012 Jan 25;9:23
[PMID:
22277195]
Sci Rep. 2020 Apr 27;10(1):7047
[PMID:
32341377]
Front Immunol. 2017 Jan 09;7:676
[PMID:
28119691]
Cell Mol Neurobiol. 2018 Apr;38(3):579-593
[PMID:
28623429]
J Lipid Res. 2010 Jun;51(6):1416-23
[PMID:
20071693]
Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):114-20
[PMID:
21810478]
Endocrinology. 2010 Oct;151(10):4916-25
[PMID:
20685874]
Ann N Y Acad Sci. 2007 Dec;1122:130-43
[PMID:
18077569]
Glia. 2007 Oct;55(13):1334-47
[PMID:
17647290]
Neuroscience. 2000;96(1):195-203
[PMID:
10683423]
Biochim Biophys Acta. 2008 Apr;1781(4):200-12
[PMID:
18316044]
Neurochem Int. 2016 Nov;100:1-10
[PMID:
27522965]
Nature. 2007 Jun 14;447(7146):869-74
[PMID:
17568749]
J Neuroinflammation. 2016 Nov 4;13(1):284
[PMID:
27809877]
